logo

For the Inventor, By the Inventor

Jeddah, Saudi Arabia

Moustafa El-Sayed El-Araby

This inventor holds 5 USPTO granted patents. Top assignees: King Abdulaziz University, Virginia Commonwealth University, The Children's Hospital of Philadelphia. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Moustafa El-Sayed El-Araby. Retrieved from https://idiyas.com/inventor/moustafa-el-sayed-el-araby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 40.0

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal5 out of 588 
 
King Abdulaziz University
 patents
silverMedal3 out of 420 
 
Virginia Commonwealth University
 patents
bronzeMedal1 out of 300 
 
The Children's Hospital of Philadelphia
 patents
where one patent can have more than one assignee

Years Active: 2019-2022

Loading Chart...
5 patents (USPTO):Explore Patents
1. 11319292 - Metabolically stable 5-HMF derivatives for the treatment of hypoxia (2022-05-03),
2. 11149012 - Metabolically stable 5-HMF derivatives for the treatment of hypoxia (2021-10-19),
3. 11104632 - Metabolically stable vanillin derivatives for the treatment of hypoxia (2021-08-31),
4. 10836729 - Metabolically stable 5-HMF derivatives for the treatment of hypoxia (2020-11-17),
5. 10344001 - Azolylacryloyl derivatives as therapeutic agents for sickle cell disease (2019-07-09),

Title: Moustafa El-Sayed El-Araby: Innovator in Medical Chemistry

Introduction

Moustafa El-Sayed El-Araby is a prominent inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of medical chemistry, particularly in the development of innovative treatments for hypoxia-related disorders. With a total of 5 patents, his work has the potential to impact the lives of many patients suffering from these conditions.

Latest Patents

Among his latest patents, Moustafa has developed metabolically stable 5-HMF derivatives for the treatment of hypoxia. These 5-HMF derivative compounds are designed to bind covalently with hemoglobin, providing a novel approach to treating sickle cell disease and other hypoxia-related disorders. The methods he has created for administering these compounds represent a significant advancement in medical treatment options.

Career Highlights

Moustafa has held positions at notable institutions, including King Abdulaziz University and Virginia Commonwealth University. His work at these universities has allowed him to collaborate with other experts in the field and further his research in medical chemistry.

Collaborations

Some of Moustafa's notable coworkers include Martin K. Safo and Abdelsattar Mansour Ebeid Omar. Their collaborative efforts have contributed to the advancement of research in the treatment of hypoxia-related disorders.

Conclusion

Moustafa El-Sayed El-Araby is a distinguished inventor whose work in medical chemistry is paving the way for innovative treatments. His patents and collaborations highlight his commitment to improving patient care and advancing scientific knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…